Use of Platelet-Rich Fibrin for Jaw Osteonecrosis: A Case Report

1. Beth-Tasdogan NH, Mayer B. Hussein, H, Zolk O. Interventions for managing medication-related osteonecrosis of the jaw. Cochrane Database Syst. Rev. 2017;10.10.1002/14651858.CD012432.pub2648585928983908Search in Google Scholar

2. El-Rabbany M, Sgro A, Lam DK, Shah PS, Azarpazhooh A. Effectiveness of treatments for medication-related osteonecrosis of the jaw: A systematic review and meta-analysis. J. Am. Dent. Assoc. 2017;148:584–94.Search in Google Scholar

3. Hasegawa T, Kawakita A, Ueda, N, Funahara R, Tachibana A, Kobayashi M, Kondou E, Takeda D, Kojima Y, Sato S et al. A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients receiving oral bisphosphonate therapy: Can primary wound closure and a drug holiday really prevent MRONJ? Osteoporos. Int. 2017;28:2465–73.10.1007/s00198-017-4063-728451732Search in Google Scholar

4. Giudice A, Barone S, Giudice C, Bennardo F, Fortunato L. Can platelet-rich fibrin improve healing after surgical treatment of medication-related osteonecrosis of the jaw? A pilot study. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 2018;126:390–403.10.1016/j.oooo.2018.06.00730108028Search in Google Scholar

5. Thakkar DJ, Deshpande NC, Dave DH, Narayankar SD. A comparative evaluation of extraction socket preservation with demineralized freeze-dried bone allograft alone and along with platelet-rich fibrin: A clinical and radiographic study. Contemp. Clin. Dent. 2016;7:371–6.Search in Google Scholar

6. Lodi G, Sardella A, Salis A, Demarosi F, Tarozzi M, Carrassi A. Tooth Extraction in Patients Taking Intravenous Bisphosphonates: A Preventive Protocol and Case Series. J. Oral Maxillofac. Surg. 2010;68:107–10.Search in Google Scholar

7. Tsolov R, Firkova E, Yordanov G. Advanced stage 3 medication-related osteonecrosis of the mandible in a cancer patient on denosumab therapy (A case report), Biocell. 2019;43(5-1):240-4.Search in Google Scholar

8. Marx RE, Sawatari Y, Fortin M, Broumand V. Bisphosphonate-induced exposed bone of the jaws: risk factors, recognition, prevention and treatment. J Oral Maxillofac Surg. 2005;63(11):1567-75.10.1016/j.joms.2005.07.01016243172Search in Google Scholar

9. Fliefel R, Tröltzsch M, Kühnisch J, Ehrenfeld M, Otto S. Treatment strategies and outcomes of bisphosphonate-related osteonecrosis of the jaw (BRONJ) with characterization of patients: a systematic review. Int J Oral Max Surg. 2015;44(5):568-85.10.1016/j.ijom.2015.01.02625726090Search in Google Scholar

10. Chisini LA, Arangurem Karam S, Noronha TG, Morello Sartori LR, Schmidt San Martin A, Demarco FF, Muniz Conde MC. Platelet-poor plasma as a supplement for fibroblasts cultured in platelet-rich fibrin. Acta stomatologica Croatica. 2017;51(2),133-40.Search in Google Scholar

11. Ji X, Pushalkar Sр, Li Y, Glickman R, Fleisher K, Saxena D. Antibiotic effects on bacterial profile in osteonecrosis of the jaw. Oral diseases. 2012;18(1),85-95.Search in Google Scholar

12. Ristow O, Pautke C. Auto-fluorescence of the bone and its use for delineation of bone necrosis. Int J Oral Max Surg. 2014; 43(11):1391-3.10.1016/j.ijom.2014.07.01725128260Search in Google Scholar

13. Tzolov R, Firkova E, Yordanov G. Comparative analysis of the healing process after conservative and surgical treatment of Medicamentally Induced Osteonecrosis of the Jaws, Bulgarian medical journal. 2019;2(21).Search in Google Scholar

14. Tsolov R, Firkova E, Chenchev I, Yordanov G, Paecheva S. Bisphosphonate – related osteonecrosis of the jaw a 3-years retrospective study of frequency and risk factors, J of IMAB – Annual Proceeding (Scientific Papers). 2019;25(3):2617-21.Search in Google Scholar